Skip to main content
Displaying 281 - 290 of 4050
# Title Department Research Year
281 Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3-(2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFRWT/EGFRT790M inhibitors Department of Pharmaceutical Organic Chemistry 2023
282 Design, synthesis, docking and mechanistic studies of new thiazolyl/thiazolidinylpyrimidine-2,4-dione antiproliferative agents Department of Pharmaceutical Organic Chemistry 2023
283 Development of a highly sensitive and eco‑friendly high‑performance thin‑layer chromatography approach for the determination of empagliflozin, pioglitazone, and rosuvastatin simultaneously in pharmaceutical preparations and different biological fluids Department of Pharmaceutical Analytical Chemistry 2023
284 Development of oral formulation of Lepidium seeds significantly decreases the high blood glucose levels in diabetic rats: in vitro formulation and in vivo antidiabetic performance 2023
285 Development of sensitive spectrofluorometric approach based on formation of pyrrolidone derivative for determination of linagliptin through condensation reaction with ninhydrin and phenylacetaldehyde: Application to content uniformity and real plasma Department of Pharmaceutical Analytical Chemistry 2023
286 Discovery and optimization of 2, 3-diaryl-1, 3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity Department of Pharmaceutical Organic Chemistry 2023
287 Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity Department of Pharmaceutical Organic Chemistry 2023
288 Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action Department of Pharmaceutical Organic Chemistry 2023
289 Editorial: Advances in metabolism and chemodiversity - focus - plant enzymes 2023
290 Effective loading of incompatible drugs into nanosized vesicles: a strategy to allow concurrent administration of furosemide and midazolam in simulated clinical settings Department of Pharmaceutics 2023